GBDC Stock +24.76% Since The Golden Star Was Identified GBDC Stock +24.76% Since The Golden Star Was Identified Unlock Golden Star List
RSI low/high Values: [ 25 - 75 ]
* StockInvest.us uses dynamically calculated RSI max/min levels to determine when stock is oversold or overbought based on historical behavior.
AI Analysis of INMB
Powered by GPT-4
Upgraded!
Stock Analysis
Risk Assessment
Trading Strategy

Inmune stock downgraded from Sell Candidate to Strong Sell Candidate after Friday trading session.
(Updated on Apr 19, 2024)

Sell candidate since Mar 28, 2024 Loss -28.77% PDF

The Inmune stock price fell by -4.89% on the last day (Friday, 19th Apr 2024) from $8.80 to $8.37. During the last trading day the stock fluctuated 8.31% from a day low at $8.30 to a day high of $8.99. The price has been going up and down for this period, and there has been a -19.05% loss for the last 2 weeks. Volume fell on the last day along with the stock, which is actually a good sign as volume should follow the stock. On the last day, the trading volume fell by -29 thousand shares and in total, 69 thousand shares were bought and sold for approximately $575.58 thousand.

The stock lies in the lower of a very wide and falling trend in the short term, and this may normally pose a very good buying opportunity. If the lower trend floor at $8.30 is broken, it will firstly indicate a stronger fall rate. Given the current short-term trend, the stock is expected to fall -17.33% during the next 3 months and, with a 90% probability hold a price between $6.86 and $10.11 at the end of this 3-month period.

Ready to grow your portfolio? Here's your beginner's guide to opening a free brokerage account.

INMB Signals & Forecast

There are few to no technical positive signals at the moment. The Inmune stock holds sell signals from both short and long-term Moving Averages giving a more negative forecast for the stock. Also, there is a general sell signal from the relation between the two signals where the long-term average is above the short-term average. On corrections up, there will be some resistance from the lines at $9.38 and $11.08. A break-up above any of these levels will issue buy signals. A sell signal was issued from a pivot top point on Friday, February 16, 2024, and so far it has fallen -40.26%. Further fall is indicated until a new bottom pivot has been found. Furthermore, there is currently a sell signal from the 3 month Moving Average Convergence Divergence (MACD). Volume fell along with the price during the last trading day, which is technical positive. One should, however, note that this stock may have low liquidity in periods, which increases the general risk.

Support, Risk & Stop-loss for Inmune stock

There is no support from accumulated volume below today's level and given the right condition the stock may perform very badly in the next couple of days.

This stock may move much during the day (volatility) and with periodic low trading volume this stock is considered to be "high risk". During the last day, the stock moved $0.690 between high and low, or 8.31%. For the last week the stock has had daily average volatility of 8.46%.

Inmune is oversold on RSI14 (22). Some stocks may drop long and hard while being oversold on RSI before turning, which increases the general risk.

Our recommended stop-loss: We hold a negative evaluation for this stock. No stop-loss is set.

Trading Expectations (INMB) For The Upcoming Trading Day Of Monday 22nd

For the upcoming trading day on Monday, 22nd we expect Inmune Bio Inc. to open at $8.55, and during the day (based on 14 day Average True Range), to move between $7.62 and $9.12, which gives a possible trading interval of +/-$0.750 (+/-8.96%) up or down from last closing price. If Inmune Bio Inc. takes out the full calculated possible swing range there will be an estimated 17.92% move between the lowest and the highest trading price during the day.

With no support below and resistance from accumulated volume @ $8.43, some $0.0600 (0.72%) from the current price of $8.37, our system finds the risk reward not very attractive.

Is Inmune Bio Inc. stock A Buy?

Inmune holds several negative signals and is within a very wide and falling trend, so we believe it will still perform weakly in the next couple of days or weeks. We therefore hold a negative evaluation of this stock. Due to some small weaknesses in the technical picture we have downgraded our analysis conclusion for this stock since the last evaluation from a Sell to a Strong Sell candidate.

Current score: -5.120 Strong Sell Candidate Downgraded

Predicted Opening Price for Inmune Bio Inc. of Monday, April 22, 2024

Fair opening price April 22, 2024 Current price
$8.55 ( 2.19%) $8.37

The predicted opening price is based on yesterday's movements between high, low, and closing price.

Trading levels for INMB

Fibonacci Support & Resistance Levels

Level Price
Resistance R3 9.24 10.43 %
R2 8.98 7.28 %
R1 8.82 5.34 %
Current price: 8.37
Support S1 8.29 -0.96 %
S2 8.13 -2.90 %
S3 7.86 -6.05 %

Accumulated Volume Support & Resistance Levels

Level Price
Resistance R3 10.36 23.78 %
R2 10.10 20.67 %
R1 8.43 0.717 %
Current price 8.37
Support S1 0 .
S2 0 .
S3 0 .

FAQ

What is the symbol for Inmune Stock and on which exchange is it traded?
The symbol for Inmune is INMB and it is traded on the NASDAQ (NASDAQ Stock Exchange).

Should I buy or sell Inmune Stock?
Inmune holds several negative signals and is within a very wide and falling trend, so we believe it will still perform weakly in the next couple of days or weeks. We therefore hold a negative evaluation of this stock. Due to some small weaknesses in the technical picture we have downgraded our analysis conclusion for this stock since the last evaluation from a Sell to a Strong Sell candidate.

How to buy Inmune Stock?
Inmune Stock can be purchased through just about any brokerage firm, including online brokerage services.
Click here for our free guide on how to buy Inmune Stock.

What's the current price of Inmune Stock?
As of the end of day on the 2024-04-19, the price of an Inmune (INMB) share was $8.37.

What is the 52-week high and low for Inmune Stock?
The 52-week high for Inmune Stock is $14.74 and the 52-week low is $6.51.

What is the market capitalization of Inmune Stock?
As of the 2024-04-19, the market capitalization of Inmune is 152.362M.

When is the next earnings date for Inmune?
The upcoming earnings date for Inmune is May 01, 2024.
Click to get the best stock tips daily for free!

About Inmune Bio Inc.

Inmune INmune Bio, Inc., a clinical-stage immunotherapy company, focuses on developing drugs to reprogram the patient's innate immune system to treat disease. The company develops and commercializes product candidates to treat hematologic malignancies, solid tumors, and chronic inflammation. Its development programs include INKmune, which focuses on treating women with relapse refractory ovarian carcinoma and patients with high-risk myelodysplastic synd... INMB Profile

Top Fintech Company

StockInvest.us featured in The Global Fintech Index 2020 as the top Fintech company of the country.

Full report by FINDEXABLE

ROCKIT